
Rozustat F 67mg/20mg Tablet
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Fenofibrate (67mg) + Rosuvastatin (20mg)
Overview Rozustat F 67mg/20mg Tablet
Lipitor-F 67mg/20mg tablets combine two lipid-reducing agents to lower elevated cholesterol and triglyceride levels in the bloodstream. This medication is indicated when lifestyle modifications (like a low-fat diet) prove insufficient. It contributes to a reduced risk of cardiovascular events. Lipitor-F 67mg/20mg may be ingested with or without food, at any time of day, but consistency in timing is recommended for adherence. Dosage is determined by your physician based on your lipid profile and response to treatment. While high cholesterol and triglycerides often have no noticeable symptoms, discontinuation can exacerbate the condition, raising the risk of heart disease and stroke. Regular lipid profile monitoring is crucial. This medication forms part of a comprehensive treatment plan encompassing a healthy diet low in fat, regular physical activity, smoking cessation, controlled alcohol consumption, and weight management. A normal diet is generally acceptable, although high-fat foods should be limited. Common, usually transient, side effects include nausea, abdominal discomfort, constipation, headache, flatulence, and myalgia. Persistent side effects, jaundice, unusual bleeding or bruising, or recurrent severe muscle pain warrant immediate medical attention. Periodic liver function tests may be advised. This medication is contraindicated in hepatic conditions (e.g., abnormal liver function tests, persistent jaundice). Inform your doctor of any kidney issues, pregnancy, pregnancy plans, or breastfeeding before initiating treatment. Diabetic patients should monitor blood glucose levels closely, as this medication might elevate blood sugar.
Primary Ingredients of Rozustat F 67mg/20mg Tablet
No information provided. A rephrased version cannot be created.
Uses of Rozustat F 67mg/20mg Tablet
Cardiovascular event prevention and hypercholesterolemia management
Major Benefits of Rozustat F 67mg/20mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rozustat F 67mg/20mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Rozustat F 67mg/20mg Tablet:
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
How to use Rozustat F 67mg/20mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 67mg/20mg Rozustat F tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Rozustat F 67mg/20mg Tablet works:
Rozustat F, a 67mg/20mg tablet, combines Fenofibrate and Rosuvastatin to reduce blood lipid levels. Fenofibrate decreases triglyceride concentrations, whereas Rosuvastatin inhibits the production of low-density lipoprotein (LDL) cholesterol. Concurrently, both components elevate high-density lipoprotein (HDL) cholesterol.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Rozustat F 67mg/20mg tablets is contraindicated.
PregnancyUNSAFE
The combination drug Rozustat F (67mg/20mg) poses a substantial risk during pregnancy. Pregnant individuals should consult their physician immediately, as research in both animals and pregnant women indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The medication Rozustat F 67mg/20mg Tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Rozustat F 67mg/20mg tablets.
KidneyCAUTION
Patients with kidney impairment should use Rozustat F 67mg/20mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Rozustat F 67mg/20mg tablets are contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Rozustat F 67mg/20mg tablets cautiously, potentially requiring dosage modification. Severe or active liver disease contraindicates the use of Rozustat F 67mg/20mg tablets; consult a physician for guidance.
What if you forget to take Rozustat F 67mg/20mg Tablet :
Should you forget a Rozustat F 67mg/20mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rozustat F 67mg/20mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
